$SHMY
Synergy Empire Ltd

2023 Q3 Form 10-Q Financial Statement

#000149315223028159 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $7.778K $7.859K $44.91K
YoY Change -86.46% -82.5% 306.53%
Cost Of Revenue $20.96K
YoY Change 425.52%
Gross Profit $7.778K $7.859K $23.95K
YoY Change -58.2% -67.18% 239.27%
Gross Profit Margin 100.0% 100.0% 53.32%
Selling, General & Admin $29.24K $52.52K $150.8K
YoY Change -82.06% -65.18% 47.3%
% of Gross Profit 375.93% 668.28% 629.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.000K $1.992K $16.16K
YoY Change -93.58% -87.67% -16.91%
% of Gross Profit 25.71% 25.35% 67.47%
Operating Expenses $31.25K $54.55K $167.0K
YoY Change -82.51% -67.34% 37.06%
Operating Profit -$23.47K -$46.69K -$143.1K
YoY Change -85.34% -67.37% 24.63%
Interest Expense $35.00 $123.00 $514.00
YoY Change -91.27% -76.07%
% of Operating Profit
Other Income/Expense, Net -$40.00 -$120.00 -$514.00
YoY Change -90.02% -76.65% -106.13%
Pretax Income -$23.50K -$46.81K -$143.6K
YoY Change -85.36% -67.4% 34.92%
Income Tax
% Of Pretax Income
Net Earnings -$23.50K -$46.81K -$143.6K
YoY Change -85.36% -67.4% 34.92%
Net Earnings / Revenue -302.19% -595.66% -319.75%
Basic Earnings Per Share -$0.02 -$0.05 -$0.14
Diluted Earnings Per Share -$0.02 -$0.05 -$143.6K
COMMON SHARES
Basic Shares Outstanding 1.000M shares 1.000M shares 1.000M shares
Diluted Shares Outstanding 1.000M shares 1.000M shares 1.000M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $340.00 $3.680K $10.19K
YoY Change -94.15% -63.89% -92.33%
Cash & Equivalents $338.00 $3.680K $10.19K
Short-Term Investments
Other Short-Term Assets $5.000K $440.00 $35.25K
YoY Change 229.38% -98.75% 42.02%
Inventory $14.31K
Prepaid Expenses $5.000K $8.750K
Receivables $300.00
Other Receivables $440.00 $443.00 $0.00
Total Short-Term Assets $5.778K $12.87K $60.05K
YoY Change -88.02% -78.56% -65.24%
LONG-TERM ASSETS
Property, Plant & Equipment $58.46K $60.76K $275.5K
YoY Change -76.42% -77.95% -56.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $59.52K $61.86K $544.3K
YoY Change -87.81% -88.64% -14.55%
TOTAL ASSETS
Total Short-Term Assets $5.778K $12.87K $60.05K
Total Long-Term Assets $59.52K $61.86K $544.3K
Total Assets $65.30K $74.73K $604.4K
YoY Change -87.83% -87.63% -25.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.585K $5.617K $11.21K
YoY Change -54.21% -49.89% 41.54%
Accrued Expenses $19.83K $24.69K $35.56K
YoY Change -56.85% -30.59% -67.77%
Deferred Revenue
YoY Change
Short-Term Debt $1.305M $1.291M $1.155M
YoY Change 7.87% 11.75% 29.39%
Long-Term Debt Due $0.00 $3.480K $16.54K
YoY Change -100.0% -78.96% 3.83%
Total Short-Term Liabilities $1.364M $1.359M $1.322M
YoY Change -1.29% 2.78% 24.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $3.760K
YoY Change -100.0% -82.62%
Other Long-Term Liabilities $204.7K
YoY Change -12.67%
Total Long-Term Liabilities $0.00 $0.00 $208.5K
YoY Change -100.0% -100.0% -18.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.364M $1.359M $1.322M
Total Long-Term Liabilities $0.00 $0.00 $208.5K
Total Liabilities $1.364M $1.359M $1.530M
YoY Change -12.61% -11.22% 15.85%
SHAREHOLDERS EQUITY
Retained Earnings -$2.205M -$2.181M -$1.743M
YoY Change 15.81% 25.12%
Common Stock $100.00 $100.00 $100.00
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.299M -$1.284M -$925.8K
YoY Change
Total Liabilities & Shareholders Equity $65.30K $74.73K $604.4K
YoY Change -87.83% -87.63% -25.37%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$23.50K -$46.81K -$143.6K
YoY Change -85.36% -67.4% 34.92%
Depreciation, Depletion And Amortization $2.000K $1.992K $16.16K
YoY Change -93.58% -87.67% -16.91%
Cash From Operating Activities -$22.54K -$48.31K -$146.9K
YoY Change -82.11% -67.11% -17.7%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $10.21K
YoY Change -100.0% -66.18%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$10.21K
YoY Change -100.0% -67.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.86K $10.92K $122.1K
YoY Change -83.15% -91.06% -3337.13%
NET CHANGE
Cash From Operating Activities -22.54K -$48.31K -$146.9K
Cash From Investing Activities 0.000 -$10.21K
Cash From Financing Activities 15.86K $10.92K $122.1K
Net Change In Cash -6.680K -$6.188K -$8.367K
YoY Change -79.8% -26.04% -96.06%
FREE CASH FLOW
Cash From Operating Activities -$22.54K -$48.31K -$146.9K
Capital Expenditures $0.00 $10.21K
Free Cash Flow -$22.54K -$48.31K -$157.1K
YoY Change -81.94% -69.25% -24.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001766267
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2023Q2 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
usd
CY2023Q1 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
usd
CY2023Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023Q2 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
333-235700
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
SYNERGY EMPIRE LIMITED
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-4096727
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
No.19 Jalan 12/118B
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Desa Tun Razak
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
56100
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Kuala Lumpur
CY2023Q2 dei Entity Address Country
EntityAddressCountry
MY
CY2023Q2 dei City Area Code
CityAreaCode
+(60)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
3 - 9171 2828
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1000000 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3680 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9868 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9193 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15681 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
12873 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
25549 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60756 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66184 usd
CY2023Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1101 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1199 usd
CY2023Q2 us-gaap Assets
Assets
74730 usd
CY2023Q1 us-gaap Assets
Assets
92932 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5617 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5928 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
58507 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
70885 usd
CY2023Q2 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
3480 usd
CY2023Q1 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
7954 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1358513 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1410075 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1358513 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1410075 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1000000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
100 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
100 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
784083 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
784083 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
113054 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
32881 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2181020 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2134207 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1283783 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1317143 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74730 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92932 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7859 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44909 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
20963 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54549 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
167029 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
54549 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
187992 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-46690 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-143083 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
123 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
514 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46813 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-143597 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-46813 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-143597 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
80173 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
53377 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33360 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-90220 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1000000 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1317143 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-46813 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
80173 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1283783 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-835619 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-143597 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
53377 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-925839 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-46813 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-143597 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2027 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31882 usd
CY2022Q2 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
699 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
740 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3664 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6370 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
642 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-57 usd
CY2023Q2 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-9893 usd
CY2022Q2 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-15365 usd
CY2022Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-15413 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48309 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-146897 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10209 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10209 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
15050 usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
126075 usd
CY2023Q2 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
4134 usd
CY2022Q2 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
3938 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10916 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
122137 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31205 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26602 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6188 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8367 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9868 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18561 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3680 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10194 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
123 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
514 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54549 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-46690 usd
CY2023Q2 us-gaap Assets
Assets
74730 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zYVLrAmyccki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_zw9oD079NVm4">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 myr
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
53557 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1992 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16157 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44909 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
20963 usd
CY2023Q2 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.
CY2023Q1 us-gaap Loans Payable To Bank
LoansPayableToBank
7954 usd
CY2023Q2 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
4134 usd
CY2022Q2 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
3938 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
167029 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7859 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2181020 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2134207 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-46813 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-143597 usd
CY2023Q2 SHMY Working Capital
WorkingCapital
1345640 usd
CY2023Q1 SHMY Working Capital
WorkingCapital
1384526 usd
CY2023Q2 us-gaap Assets
Assets
74730 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44909 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
20963 usd
CY2023Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
7859 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7859 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8750 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12500 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
443 usd
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3181 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9193 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15681 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88673 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
93585 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27917 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27401 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60756 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66184 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24685 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31322 usd
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
33394 usd
CY2023Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
39111 usd
CY2023Q2 SHMY Deposit Received
DepositReceived
428 usd
CY2023Q1 SHMY Deposit Received
DepositReceived
452 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
58507 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
70885 usd
CY2023Q2 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
3480 usd
CY2023Q1 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
7954 usd
CY2023Q2 us-gaap Loans Payable To Bank
LoansPayableToBank
3480 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3480 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
3480 usd
CY2023Q2 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-43854 usd
CY2022Q2 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-40188 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46813 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-143597 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
167029 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-143083 usd
CY2022Q2 us-gaap Assets
Assets
604353 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10209 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7859 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
383182 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
373470 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
383182 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
373470 usd
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7859 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54549 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-46690 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-143083 usd
CY2022Q2 us-gaap Assets
Assets
604353 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10209 usd

Files In Submission

Name View Source Status
0001493152-23-028159-index-headers.html Edgar Link pending
0001493152-23-028159-index.html Edgar Link pending
0001493152-23-028159.txt Edgar Link pending
0001493152-23-028159-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
shmy-20230630.xsd Edgar Link pending
Show.js Edgar Link pending
shmy-20230630_cal.xml Edgar Link unprocessable
shmy-20230630_def.xml Edgar Link unprocessable
shmy-20230630_lab.xml Edgar Link unprocessable
shmy-20230630_pre.xml Edgar Link unprocessable